VIA
BMY icon

Vantage Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Vantage Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$400K Buy
6,451
+597
+10% +$35.4K 0.08% 110
2018
Q2 		$324K Buy
5,854
+3
+0.1% +$162 0.08% 113
2018
Q1 		$370K Sell
5,851
-873
-13% -$56.2K 0.09% 106
2017
Q4 		$412K Buy
6,724
+878
+15% +$54.9K 0.09% 109
2017
Q3 		$373K Buy
5,846
+3
+0.1% +$175 0.1% 103
2017
Q2 		$326K Sell
5,843
-583
-9% -$31.7K 0.09% 105
2017
Q1 		$349K Buy
6,426
+15
+0.2% +$823 0.11% 99
2016
Q4 		$375K Sell
6,411
-64
-1% -$3.5K 0.15% 90
2016
Q3 		$349K Sell
6,475
-40
-0.6% -$2.57K 0.16% 85
2016
Q2 		$477K Buy
6,515
+95
+1% +$6.71K 0.2% 74
2016
Q1 		$410K Sell
6,420
-197
-3% -$12.4K 0.18% 81
2015
Q4 		$455K Buy
6,617
+217
+3% +$14.3K 0.23% 72
2015
Q3 		$379K Buy
6,400
+1,938
+43% +$123K 0.21% 77
2015
Q2 		$297K Sell
4,462
-3,393
-43% -$224K 0.16% 92
2015
Q1 		$507K Buy
7,855
+4,620
+143% +$289K 0.14% 95
2014
Q4 		$191K Buy
3,235
+973
+43% +$54.9K 0.11% 114
2014
Q3 		$116K Buy
2,262
+100
+5% +$5K 0.07% 144
2014
Q2 		$105K Hold
2,162
– – 0.06% 160
2014
Q1 		$112K Buy
2,162
+600
+38% +$31.9K 0.07% 150
2013
Q4 		$83K Buy
+1,562
New +$79.6K 0.06% 171

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vantage Investment Advisors's BMY Position: Q3 2018 in Review

Vantage Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2018, buying an estimated $35.4K and bringing the position to 6,451 shares worth $400K. The position accounts for 0.08% of the portfolio, ranked #110.

Vantage Investment Advisors first reported a position in BMY in Q4 2013 and has held it in 20 quarters since. The position peaked at $507K in Q1 2015. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

  • Vantage Investment Advisors held 6,451 shares of Bristol-Myers Squibb worth $400K as of Q3 2018.
  • Vantage Investment Advisors bought 597 Bristol-Myers Squibb shares in Q3 2018, an estimated $35.4K.
  • Bristol-Myers Squibb made up 0.08% of Vantage Investment Advisors's portfolio in Q3 2018, its #110 holding.
  • Vantage Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 20 quarters since.
  • Vantage Investment Advisors's Bristol-Myers Squibb position peaked at $507K in Q1 2015.
  • 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.